LOUISVILLE, Ky. and STAMFORD, Conn., March 17, 2025 /PRNewswire/ -- Senior-focused primary care providers CenterWell Senior Primary Care® and Conviva Senior Primary Care® are now partnering with Icon Health, a leading provider of value-based musculoskeletal healthcare, to provide seniors with convenient access to quality, integrated musculoskeletal care in their primary care centers.
Musculoskeletal conditions, including back pain, arthritis, and joint injuries, are among the primary causes of disability in the senior population. These conditions often require coordinating care between orthopedic specialists, physical therapists and primary care physicians. The partnership embeds specialized advanced practice providers in the primary care centers to deliver care in-person and virtually, ensuring convenience for seniors while improving their health outcomes. This care model is available throughout Palm Beach County via virtual care delivery, or telehealth appointments, and in-person with specialists.
"This collaboration is advancing the delivery of whole-person musculoskeletal care," said Dr. Evan Jacobs, Associate Vice President for Specialty Care at CenterWell and Conviva. "We're encouraged by the early results showing that by integrating Icon Health's specialized, team-based approach, we're making it easier for our members to access comprehensive treatment. This is another way CenterWell and Conviva are partnering with specialty care providers to better address conditions prevalent among seniors."
Specialist Value-Based Care Model Results in Better Outcomes
Icon's value-based care model prioritizes early intervention, precise diagnosis and personalized treatment plans. Seniors will benefit from:
"This partnership reflects a shared commitment to advancing value-based care and delivering exceptional health outcomes," said Duncan Sibson, Chief Executive Officer for Icon Health. "By partnering with CenterWell and Conviva Senior Primary Care, we're bridging the gap between value-based primary care and specialty value-based musculoskeletal care."
CenterWell and Conviva accept patients with Original Medicare and a wide range of Medicare Advantage plans. Icon Health accepts those same health plans, offering even more ease and convenience for patients.
For more information about CenterWell and Conviva, contact:
Lisa Ferguson
This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information about Icon Health, contact:
Duncan Sibson
This email address is being protected from spambots. You need JavaScript enabled to view it.
About CenterWell
CenterWell Senior Primary Care and Conviva Senior Primary Care are part of CenterWell, a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and most of all, personalized. As the largest provider of senior-focused primary care, one of the leading providers of home health care, and a leading integrated home delivery, specialty, hospice, and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.
About Icon Health
Icon Health is a leading provider of value-based musculoskeletal care, leveraging a virtual-first approach to deliver multidisciplinary, evidence-based treatment. Icon's specialized care model ensures that each patient is paired with the optimal specialists, treatments, and recovery plans personalized for their individual MSK health needs.

| Last Trade: | US$260.28 |
| Daily Change: | 2.12 0.82 |
| Daily Volume: | 1,038,961 |
| Market Cap: | US$31.300B |
December 16, 2025 November 05, 2025 October 20, 2025 August 27, 2025 | |

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load